(lp0
S"Better Buy: Myriad Genetics, Inc. vs. Opko Health, Inc. Motley Fool - Mar 11, 2017 It's been a rough 12 months for Myriad Genetics  and Opko Health . Myriad lost nearly half of its market cap during the period, while Opko stock is down around 20%."
p1
aS'Myriad Genetics  Launches EndoPredict Test in the US Zacks.com - Mar 14, 2017 Myriad Genetics, Inc.  , a leading name in the molecular diagnostics space, recently launched the EndoPredict test in the U.S.Myriad Genetics, Inc.  Stock Rating Upgraded by Stephens - Chaffey Breeze'
p2
aS'Why Myriad Genetics, Inc. Stock Dropped 61% in 2016 Motley Fool - Jan 13, 2017 Shares of Myriad Genetics, Inc. , a DNA diagnostics specialist, dropped 61.4% last year, according to data from S&amp;P Global Market Intelligence.'
p3
aS"3 Big Stock Charts for Thursday: Myriad Genetics, Inc. , Wal-Mart Stores ... Investorplace.com - Mar 2, 2017 For weeks, the market and certain sectors have been operating under uncertainty as doubts over the direction of President Trump's administration were growing."
p4
aS"Noteworthy Stock: Myriad Genetics, Inc.  Is stories - Mar 13, 2017 Myriad Genetics, Inc.'s  witnessed a gain of 0.84% in recent trading period with closing price of $ 19.31."
p5
aS'Myriad Genetics, Inc.  Upgraded to C by TheStreet BNB Daily  - Mar 7, 2017 TheStreet upgraded shares of Myriad Genetics, Inc.  from a d+ rating to a c rating in a research note issued to investors on Wednesday morning.Stree Opinion on Myriad Genetics, Inc.  - Highland Mirror'
p6
aS'Stock Returns: Momenta Pharmaceuticals Inc  is Beating Myriad ... CML News - Feb 21, 2017 This is a snapshot to compare the stock returns for Momenta Pharmaceuticals Inc  versus Myriad Genetics Inc  .'
p7
aS'Stock Returns: Exelixis Inc  is Beating Myriad Genetics Inc ... CML News - Feb 27, 2017 This is a snapshot to compare the stock returns for Exelixis Inc  versus Myriad Genetics Inc  . The stock return points we compare look at the last three-months, six-months and twelve-months.Analyst Viewpoints on Price Target Estimates: Myriad Genetics, Inc.  - Post RegistrarJohn T. Henderson Acquires 6000 Shares of Myriad Genetics, Inc.  Stock - The Cerbat Gem'
p8
aS"Myriad's Prolaris Test Significantly Improves the Risk Classification for One ... GlobeNewswire  - Feb 17, 2017 SALT LAKE CITY, Feb. 17, 2017  -- Myriad Genetics, Inc. , a global leader in personalized medicine, today announced new data demonstrating the utility of the Prolaris test to more accurately classify mortality risk and&nbsp;..."
p9
aS'Steady Activities: Myriad Genetics, Inc.  TopChronicle - Feb 22, 2017 On Dec 16 Myriad Genetics, Inc.  reported its EPS in the last quarter as $0.26/Share beating the analyst estimate of $0.24/Share by the difference of $0.02.'
p10
a.